Holen Sie sich die Stockscreener-App
129.76
3.92%
4.155
Schlusskurs vom Vortag:
$125.61
Offen:
$129.32
24-Stunden-Volumen:
388.07K
Relative Volume:
0.41
Marktkapitalisierung:
$7.32B
Einnahmen:
$738.26M
Nettoeinkommen (Verlust:
$48.89M
KGV:
150.10
EPS:
0.8645
Netto-Cashflow:
$91.69M
1W Leistung:
+15.40%
1M Leistung:
+11.62%
6M Leistung:
-9.96%
1J Leistung:
+0.10%
1-Tages-Spanne:
$125.21
$131.53
1-Wochen-Bereich:
$112.97
$131.53
52-Wochen-Spanne:
$109.50
$175.77
Repligen Corp Stock (RGEN) Company Profile
Firmenname
Repligen Corp
Sektor
Telefon
(781) 449-9560
Adresse
41 SEYON STREET, WALTHAM, MA
Compare RGEN vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
129.77 | 7.08B | 738.26M | 48.89M | 91.69M | 0.8645 |
ISRG
Intuitive Surgical Inc
|
450.80 | 159.86B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.11 | 41.01B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
41.53 | 38.32B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
66.33 | 36.29B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
211.25 | 30.15B | 5.40B | 1.49B | 1.78B | 10.12 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-17 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-10-01 | Eingeleitet | HSBC Securities | Buy |
| 2025-09-22 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-29 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Eingeleitet | Evercore ISI | In-line |
| 2025-02-10 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-04 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-03-28 | Eingeleitet | The Benchmark Company | Buy |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2021-10-14 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-23 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-11-01 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-28 | Bestätigt | First Analysis Sec | Outperform |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2019-07-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Hochstufung | CL King | Neutral → Buy |
| 2018-11-12 | Herabstufung | CL King | Buy → Neutral |
| 2018-09-26 | Eingeleitet | H.C. Wainwright | Neutral |
| 2017-12-08 | Eingeleitet | Citigroup | Buy |
| 2017-12-05 | Eingeleitet | JP Morgan | Overweight |
| 2017-11-13 | Eingeleitet | CL King | Buy |
| 2017-10-02 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Eingeleitet | William Blair | Outperform |
| 2017-02-13 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Repligen Corp Aktie (RGEN) Neueste Nachrichten
Repligen Corporation (NASDAQ:RGEN) Q1 2026 Earnings Call Transcript - Insider Monkey
Repligen Reshapes Operations And China Reach As Valuation Signals Upside - Yahoo Finance UK
Repligen Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Repligen (RGEN) Shares Skyrocket, What You Need To Know - FinancialContent
Repligen Q1 2026 slides: analytics surge drives 23% EPS growth - Investing.com
Earnings call transcript: Repligen beats Q1 2026 forecasts, stock rises - Investing.com
Repligen Corp (NASDAQ:RGEN) Sees Pre-Market Gain After Q1 Earnings Beat Offsets Slight Revenue Miss - ChartMill
Repligen’s (NASDAQ:RGEN) Q1 CY2026 Sales Beat Estimates - FinancialContent
Repligen: Q1 Earnings Snapshot - Barchart
REPLIGEN ($RGEN) Releases Q1 2026 Earnings - Quiver Quantitative
Repligen (NASDAQ: RGEN) posts 15% Q1 revenue growth and lifts 2026 EPS view - Stock Titan
Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance - Yahoo! Finance Canada
Repligen in the spotlight: Quarterly earnings test growth outlook By Investing.com - Investing.com South Africa
Repligen in the spotlight: Quarterly earnings test growth outlook - Investing.com
Repligen (RGEN) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Repligen Corporation $RGEN Shares Sold by Vanguard Group Inc. - MarketBeat
Repligen Corporation $RGEN Holdings Raised by Artemis Investment Management LLP - MarketBeat
Repligen Corporation (NASDAQ:RGEN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Conestoga Capital Advisors LLC Buys 101,062 Shares of Repligen Corporation $RGEN - MarketBeat
RGEN SEC FilingsRepligen 10-K, 10-Q, 8-K Forms - Stock Titan
Delta Investment Management LLC Reduces Stake in Repligen Corporation $RGEN - MarketBeat
Is Repligen Corp (RGEN) a Bargain After 3.7% Drop? GF Value Says Undervalued - GuruFocus
Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Tempered Forward Expectations Hurt Repligen Corp. (RGEN) in Q1 - Yahoo Finance
Impax Asset Management Group plc Sells 289,853 Shares of Repligen Corporation $RGEN - MarketBeat
A Look at Repligen Corp (RGEN) After 3.1% Gain -- GF Value $173. - GuruFocus
Repligen slides 8.3% as CEO share sale disclosure weighs on sentiment - Quiver Quantitative
Repligen Corporation stock hits 52-week low at 109.66 USD - Investing.com
Repligen Corporation stock hits 52-week low at 109.66 USD By Investing.com - Investing.com Canada
M&T Bank Corp Purchases New Holdings in Repligen Corporation $RGEN - MarketBeat
Why Repligen (RGEN) Shares Are Plunging Today - Yahoo Finance
Repligen Corp (RGEN) Stock Down 6.2% -- Now Undervalued? GF Scor - GuruFocus
Insider Sell: Olivier Loeillot Sells Shares of Repligen Corp (RG - GuruFocus
Repligen CEO Loeillot sells $536,480 in company stock By Investing.com - Investing.com India
Repligen CEO Loeillot sells $536,480 in company stock - Investing.com
Repligen Corp (RGEN) CEO sells 3,832 shares under 10b5-1 plan - Stock Titan
Repligen to Report First Quarter 2026 Financial Results - ChartMill
Repligen plans a May 5 premarket earnings release and 8 a.m. webcast - Stock Titan
Assessing Repligen (RGEN) Valuation After Recent Share Price Rebound - Yahoo Finance
Goldman Sachs (GSCE) priced capped notes linked to Repligen (RGEN) stock - Stock Titan
[144] REPLIGEN CORP SEC Filing - Stock Titan
Here’s What Positioned Repligen Corporation (RGEN) for a Durable Long-Term Growth - Insider Monkey
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know - Yahoo Finance
Repligen Corp stock (US7607591002): Is its bioprocessing dominance strong enough to unlock new upsid - AD HOC NEWS
Repligen opens third training center in Netherlands facility By Investing.com - Investing.com South Africa
Repligen opens third training center in Netherlands facility - Investing.com
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network - ChartMill
Rothschild Redburn initiates Repligen stock with buy on bioprocessing strength By Investing.com - Investing.com South Africa
Rothschild Redburn initiates Repligen stock with buy on bioprocessing strength - Investing.com Australia
Repligen (RGEN) Celebrates Opening of New Training & Innovation Center in the Netherlands - GuruFocus
Repligen Corp (RGEN) Shares Fall 3.7% -- What GF Score of 85 Tel - GuruFocus
Finanzdaten der Repligen Corp-Aktie (RGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):